Fumagalli, Giorgio Giulio
 Distribuzione geografica
Continente #
AS - Asia 3.549
NA - Nord America 3.395
EU - Europa 2.076
SA - Sud America 726
AF - Africa 94
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.861
Nazione #
US - Stati Uniti d'America 3.249
SG - Singapore 1.550
IT - Italia 719
CN - Cina 683
BR - Brasile 614
VN - Vietnam 522
RU - Federazione Russa 243
GB - Regno Unito 219
KR - Corea 171
DE - Germania 165
FR - Francia 157
LV - Lettonia 141
HK - Hong Kong 130
ID - Indonesia 118
IN - India 102
FI - Finlandia 91
CA - Canada 81
NL - Olanda 79
AT - Austria 76
IQ - Iraq 50
BD - Bangladesh 48
MX - Messico 45
AR - Argentina 35
JP - Giappone 34
PL - Polonia 27
ZA - Sudafrica 27
PK - Pakistan 26
EC - Ecuador 23
IE - Irlanda 23
ES - Italia 19
AU - Australia 18
TR - Turchia 17
GR - Grecia 15
HU - Ungheria 15
SA - Arabia Saudita 15
UA - Ucraina 13
JO - Giordania 12
MA - Marocco 12
BE - Belgio 11
CL - Cile 11
PT - Portogallo 11
SE - Svezia 11
VE - Venezuela 11
KE - Kenya 9
TN - Tunisia 9
EG - Egitto 8
PE - Perù 8
PH - Filippine 8
PY - Paraguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DZ - Algeria 7
CH - Svizzera 6
ET - Etiopia 6
JM - Giamaica 6
UY - Uruguay 6
IR - Iran 5
LB - Libano 5
OM - Oman 5
RS - Serbia 5
BG - Bulgaria 4
GE - Georgia 4
PA - Panama 4
SN - Senegal 4
AL - Albania 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
GA - Gabon 2
GH - Ghana 2
HN - Honduras 2
IL - Israele 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
GM - Gambi 1
HR - Croazia 1
Totale 9.847
Città #
Singapore 974
Ashburn 547
San Jose 524
Trento 330
Dallas 267
Santa Clara 248
Columbus 239
Council Bluffs 217
Seoul 167
Ho Chi Minh City 158
Riga 141
Moscow 137
Hanoi 133
Hong Kong 126
Hefei 125
Lauterbourg 114
Los Angeles 113
Jakarta 94
Nuremberg 78
The Dalles 74
New York 68
London 61
Washington 60
Chicago 59
São Paulo 58
Redondo Beach 54
Beijing 52
Buffalo 50
Orem 46
Da Nang 43
Milan 42
Munich 42
Rome 42
Lappeenranta 40
Helsinki 33
Salt Lake City 32
Frankfurt am Main 30
Tokyo 30
Amsterdam 29
Vienna 25
Haiphong 24
Montreal 22
Rio de Janeiro 21
Warsaw 21
Boardman 20
Dublin 19
Guangzhou 19
Chennai 18
Baghdad 17
Belo Horizonte 16
Curitiba 16
Denver 15
Paris 15
Shanghai 15
Tampa 15
Turku 14
Brooklyn 13
Budapest 13
Mumbai 13
North Bergen 13
Toronto 13
Mexico City 12
Atlanta 11
Bassano del Grappa 11
Florence 11
Johannesburg 11
Biên Hòa 10
Brasília 10
Charlotte 10
Elk Grove Village 10
Manchester 10
Ottawa 10
Phoenix 10
Quito 10
Amman 9
Campinas 9
Erbil 9
Houston 9
New Delhi 9
Seattle 9
Tempe 9
Daiano 8
Dhaka 8
Imperia 8
Islington 8
Porto Alegre 8
Tashkent 8
Athens 7
Brisbane 7
Bến Tre 7
Cairo 7
Dongguan 7
Guarulhos 7
Kilburn 7
Nairobi 7
Philadelphia 7
Pune 7
Salvador 7
Sydney 7
Zhengzhou 7
Totale 6.392
Nome #
The search for a link between autism spectrum disorder and neurodegenerative dementia 232
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 220
Tango and physiotherapy interventions in Parkinson’s disease: a pilot study on efficacy outcomes on motor and cognitive skills 129
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 128
Utility of visual rating scales in primary progressive aphasia 116
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 115
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 114
Mental State Recognition Deficits Linked to Brain Changes in Parkinson's Disease Without Dementia 114
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes 108
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 107
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 104
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 102
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 98
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 97
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 96
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 94
The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint 94
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study 92
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 92
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study 91
Clinical Heterogeneity in Alzheimer’s Disease: A Possible New Amnesic Phenotype 91
MRI visual rating scales in the diagnosis of dementia: Evaluation in 184 post-mortem confirmed cases 89
Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia 86
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: A GENFI study 85
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study 85
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status 82
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers 82
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia 81
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage 81
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 80
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 80
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 80
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 79
Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease 78
Predictor model for mild cognitive impairment in Parkinson’s disease using visual rating scales 78
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 78
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 78
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis 78
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 77
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 77
The Italian fund for Alzheimer's and other dementias: strategies and objectives to face the dementia challenge 76
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 76
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 76
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 74
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 74
The potential of neurovascular modulation with tDCS: an exploratory analysis in older adults with hypertension. 74
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 73
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 72
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 72
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 72
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia 71
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 71
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 71
Teaching NeuroImage: Crowned Dens Syndrome: An Acute Attack of Calcium Pyrophosphate Deposition Disease Mimicking Acute Meningitis 70
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 70
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 70
Education modulates brain maintenance in presymptomatic frontotemporal dementia 69
Altered plasma protein profiles in genetic FTD - a GENFI study 69
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 67
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 67
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 67
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 67
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 67
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 67
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort 67
Differential early subcortical involvement in genetic FTD within the GENFI cohort 66
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 66
A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort 65
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 65
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis 65
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters 65
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration 65
Caregiver Tele-Assistance for Reduction of Emotional Distress during the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience 65
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 64
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 64
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 63
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 63
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia 63
The role of sex and education in the clinical manifestation and progression of Posterior Cortical Atrophy. 63
Disease-related cortical thinning in presymptomatic granulin mutation carriers 63
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 63
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 62
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 62
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes 62
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 62
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 62
Crossing Borders between Frontotemporal Dementia and Psychiatric Disorders: An Updated Overview 61
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 61
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 60
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 60
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia 60
Unravelling the Association between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+? 59
Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling 59
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study 58
Behavioral and neurophysiological effects of transcranial direct current stimulation (tDCS) in fronto-temporal dementia 58
Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting 58
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 58
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort 58
Sulcation morphology analysis for differentiating behavioral variant frontotemporal dementia from psychiatric disorders. 57
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 57
Totale 7.899
Categoria #
all - tutte 53.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 517
Totale 54.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023528 0 0 0 50 255 99 26 26 25 5 10 32
2023/2024977 5 12 77 30 78 215 159 91 10 87 68 145
2024/20252.778 62 31 140 473 118 375 67 79 412 342 307 372
2025/20266.021 236 152 749 1.000 870 446 1.220 183 523 642 0 0
Totale 10.304